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Autophagy is a cellular degradation system for maintaining cellular 
homeostasis under various stress signals such as nutrient deprivation, hypoxic 
condition, or endoplasmic reticulum stress. To overcome the stress conditions, 
cells utilize autophagy-specific proteins to generate double-membrane vesicle 
called autophagosome to sequester cytosolic components and subcellular 
organelles fusing with lysosome. However, the precise roles of ATGs and 
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their regulatory mechanisms are still unknown. To identify novel regulators 
of autophagy, I employed cell-based functional screening assays using 
bimolecular fluorescence complementation (BiFC) method.  
I found an interaction between ULK1 and ATG9 in mammalian cells 
and utilized the interaction to identify novel regulators of autophagy upstream 
of ULK1, an initiation step. I established a cell-based screening assay 
employing N-terminal Venus-tagged ULK1 and C-terminal Venus-tagged 
ATG9 BiFC. By performing gain-of-function screening, I identified G6PT as 
an autophagy activator. G6PT enhanced the interaction between N-terminal 
Venus (VN)-tagged ULK1 and C-terminal Venus (VC)-tagged ATG9, and 
increased autophagic flux independent of its transport activity. G6PT 
negatively regulated mTORC1 activity, demonstrating that G6PT functions 
upstream of mTORC1 in stimulating autophagy  
Also, ATG7-VN/VCn-ATG12 BiFC assay was employed to isolate 
autophagy modulators which regulate ATG7, an E1-like activating enzyme 
for ATG12. Utilizing the assay, ZAK was isolated as a potent autophagy 
activator on elongation step. Expression of ZAK enhanced the fluorescence 
of ATG7-VN/VCn-ATG12 BiFC assay and increased the interaction between 
them. ZAK reduced the levels of p62 and ubiquitin conjugates increasing LC3 
dot formation. Conversely, malfunction of ZAK expression inhibits 
autophagy flux. Interestingly, depletion of ZAK blocked amino-acid or serum 
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starvation-induced autophagy to almost control level. Furthermore, ZAK 
interacted with ATG7 in mammalian cells. I hypothesize that ZAK is an 
essential regulator for autophagy activity functioning through its kinase 
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 Autophagy is a common cellular catabolic process involving 
formation of autophagosome for bulk degradation of proteins via lysosomal 
pathway. Despite the importance of understanding its regulatory mechanism, 
the initiation step of autophagy is largely unknown. Here, I show that G6PT 
regulates autophagy through ULK1 and ATG9. I have found protein-protein 
interaction between ULK1 and ATG9 in mammalian cells and utilized the 
interaction to identify the novel regulators at the initiation step of autophagy. 
I have established a cell-based screening assay employing ULK1-VN and 
ATG9-VC bimolecular fluorescence complementation (BiFC) assay in live 
cells. By performing gain-of-functional screening using cDNA expression, I 
isolated G6PT as a potent autophagy activator enhancing the fluorescence of 
ULK1-VN and ATG9-VC BiFC. Accordingly, ectopic expression of G6PT 
increased the binding between ULK1-VN and ATG9-VC and autophagy flux, 
while knockdown of G6PT expression reduced LC3 dot formation and LC3-
II conversion. An increase of autophagic flux by G6PT was through the 
canonical pathway mediated by ATG5 and full-length of G6PT was required 
for autophagy regulation independently of its transport activity. In addition, 
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depletion of G6PT caused the activation of mTORC1, resulting in the 
inhibition of autophagy induced by Rapamycin, amino acid-starvation, or 
serum-starvation. These data suggest that G6PT stimulates autophagic flux 






Macroautophagy, autophagy hereafter, is an intracellular degradation 
system and is initiated by the formation of a double-membrane vesicle, called 
an autophagosome, which fuses with lysosomes to degrade cytoplasmic 
components (Yang and Klionsky, 2010). Unlike the ubiquitin-proteasome 
cascade which specifically targets its substrates by ubiquitnation, autophagy 
degrades subcellular organelles such as mitochondria, peroxisomes and large 
protein aggregates (Hara et al., 2006). Since autophagy contributes to cell 
growth, adaptation, and differentiation, its malfunction is intimately 
associated with human diseases including cancer and neurodegenerative 
diseases (Jiang and Mizushima, 2014; Kesidou et al., 2013; Nixon, 2013). In 
early stages of tumorigenesis, autophagy prevents tumor formation by 
removing the damaged organelles and maintaining genome stability (Matsui 
et al., 2013). However, as the tumor develops, autophagy gives an advantage 
to cancer cells for survival. In neurodegenerative diseases, such as 
Alzheimer’s disease and Huntington’s disease, the impaired fusion of 
autophagosomes and lysosome and reduced expression of Beclin 1 and ATG7 
polymorphism (V471A) were observed in patient’s specimens (Kesidou et al., 
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2013). Recent study revealed that atg5 overexpressed transgenic mice showed 
longevity phenotype meaning that autophagy could regulate the ageing 
process (Pyo et al., 2013). 
Autophagy is tightly regulated by nutritional condition to control the 
cellular metabolic homeostasis. Autophagy is activated under nutrient 
deprivation to maintain cellular metabolic homeostasis (Russell et al., 2014). 
Amino acid starvation induces autophagy by inhibiting mTORC1, which is 
under the modulation of Rag GTPases (Sancak et al., 2010). During nutrient 
supplemented condition, mTORC1 inhibits autophagy by phosphorylating 
ULK1 (Jung et al., 2009) and AMBRA, an E3 ligase, to ubiquitinate ULK1 
for degradation (Nazio et al., 2013). During glucose starvation, AMPK 
activates ULK1 and TSC2 or inhibits Raptor to activate autophagy (Inoki et 
al., 2003; Kim et al., 2011). Not only controlled by nutrient condition, 
autophagy is also regulated by cellular stresses. ER stress affects starvation-
induced autophagy through eIF2α (Kouroku et al., 2007; Talloczy et al., 2002). 
However, prolonged ER stress impairs autophagy via IRE1 (Lee et al., 2012). 
During hypoxia, HIF1α increases BNIP3 and BNIP3L (NIX) to initiate 
autophagy (Bellot et al., 2009), and PERK increases LC3 and ATG5 to control 
autophagosome formation (Rouschop et al., 2010). In line with the 
identification of new autophagy signals, elucidation of signal modulators is 
necessary for a better understanding of the autophagy mechanism. 
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To date, about 30 autophagy-related genes (ATGs) have been 
reported to be required for autophagosome biogenesis (Feng et al., 2014). 
During autophagosome formation, ATG proteins are recruited to isolation 
membrane, a precursor of autophagosome, and functions to elongation, 
curvature, and completion of auotphagosome. Once autophagome is 
completed, most of ATG proteins are detached from autophagosme. ULK1 
complex and class III PI3K complex functions at the initiation/nucleation step. 
Briefly, ULK1 directly initiate autophagy by upstream kinases such as 
mTORC1 or AMPK. Class III PI3K generates PI3P which is recognized by 
FYVE domain (Four cysteine-rich proteins: Fab 1 (yeast orthologue of 
PIKfyve), YOTB, Vac 1 (vesicle transport protein), and EEA1). FYVE 
domain containing proteins were recruited to autophagosome assembly site 
(PAS) to elongate. Two different ubiquitin-like conjugation systems have 
been reported for autophagosome elongation step. ATG12 and LC3 act like 
ubiquitin to conjugate with ATG5 and phosphatidylethanolamine (PE). 
Similar to ubiquitin system, ATG12 and LC3 are first activated by ATG7, an 
E1-like enzyme, then transferred to ATG10 or ATG3, an E2-like enzymes. 
Finally, ATG12 forms phosphodiester bond with ATG5. ATG5 further interact 
with ATG16L1 which forms homodimer. ATG12-ATG5-ATG16L1 complex 
functions as E3 ligase for LC3-PE conjugation. Autophagosome further fuses 
with lysosomes. Then inner membrane and sequestered contents in 
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autophagosome were degraded by lysosomal hydrolases and further released 
to cytosol. 
ULK1 is required for the initiation step of autophagy. ULK1, a 
serine/threonine kinase, forms complexes with FIP200, ATG13, and ATG101 
(Ganley et al., 2009; Hosokawa et al., 2009), and the complexes are mainly 
controlled by mTORC1 (Ganley et al., 2009; Jung et al., 2009) and AMPK 
(Kim et al., 2011). The kinase activity of ULK1 is required for the recruitment 
of VPS34 (PI3K) to isolation membrane (Itakura and Mizushima, 2010; 
Koyama-Honda et al., 2013). Unlike other ATG proteins, ATG9 is the only 
membrane protein containing six trans-membrane domains. The function of 
ATG9 supposed to deliver membrane source for autophagosome expansion, 
because it shuttles between autophagosomes and the trans Golgi network 
during autophagosome biogenesis (Young et al., 2006). The movement of 
ATG9 is dependent on the activity of the ULK1 with class III PI3K complex. 
Moreover, like ATG16L1, ATG9 functions to traffic vesicles derived from the 
plasma membrane (Puri et al., 2014). In yeast, Atg1, an ULK1 homolog, 
interacts with Atg9 through Atg17, a counterpart of FIP200, and the 
interaction is increased by autophagy activation (Sekito et al., 2009). A recent 
study also reported an interaction between Atg1 and Atg9 in Drosophila 
during starvation-induced autophagy (Tang et al., 2013). However, this 
interaction has not been revealed in higher eukaryotes. 
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There are numerous analyses to verify protein-protein interaction. 
Among them, Bimolecularfluorescence complementation assay (BiFC 
hereafter) is one of the most superior methods to visualize protein-protein 
interaction in living cells. The BiFC assay is based on the structural 
complementation between two non-fluorescent N-terminal and C-terminal 
fragments of a fluorescent protein. The interaction between the fusion 
proteins facilitates the association between the fragments of the fluorescent 
protein. Not only for visualize protein interaction, BiFC also has been used 
for screening method to identify interactor partners or modifiers of known 
interactor proteins. It also has been implied screening of small molecule 
modulators, as those modifiers could change the intensity of fluorescence 
produced by BiFC assay (Kodama and Hu, 2012). 
Glucose-6-phosphate transporter (G6PT) is embedded in the ER 
membrane by 10 transmembrane domains with its both N- and C- termini on 
the cytoplasmic side of the ER membrane (Pan et al., 2009). It functions to 
transport cytosolic glucose-6-phosphate (G6P) into the ER lumen during 
gluconeogenesis or glycogenolysis by complexing with glucose-6-
phosphatase (G6Pase)-α (in the liver, kidney, and intestine) or -β (in 
neutrophils). Translocated G6P by G6PT is hydrolyzed to glucose and 
phosphate by G6Pase at the ER lumen where the active site of G6Pase faces. 
Accordingly, deficiency of G6Pase complex cause glycogen storage disease; 
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cause of G6Pase-α named GSD1a and cause of G6PT named GSD1b leading 
to the homeostatic imbalance of glucose (Froissart et al., 2011). However, 
unlike GSD1a, GSD1b patients show typical phenomenon such as 
neutropenia, neutrophil dysfunction. More than 160 mutations have been 
revealed as the causes of GSD1b in patients which disrupt transport activity 
of G6PT. 
To identify novel regulators of the initiation step of autophagy, I 
performed cell-based functional screening using cDNA expression library. I 
identified G6PT as an autophagy activator and hypothesized that it regulates 
autophagy both basal and starvation-induced autophagy through mTORC1 




Materials and Methods 
 
DNA Constructs 
The cDNA of G6PT was amplified by PCR using synthetic oligonucleotides 
(forward 5'-CCC AAG CTT GGG ATG GCA GCC CAG GGC TA-3' and 
reverse 5'- CCC AAG CTT GGG CTC AGC CTT CTT GGA CA-3') and the 
PCR products were subcloned into HindIII site of pcDNA3-HA (Invitrogen). 
Deletion constructs of G6PT were amplified by PCR and subcloned into 
HindIII site of pcDNA3-HA (8TM reverse 5'- CCC AAG CTT GGG AAA 
CAG GGC AAT GGG-3' and 4TM reverse 5'- CCC AAG CTT GGG GAT 
GAG CAG GAG ACA-3'). The G6PT shRNAs were constructed using 
forward and reverse synthetic 19-nucleotides (#1, 1243-CGA AAC ATC CGC 
ACC AAG A-1261, #2, 107-CAT CAT TGG TGG AAG AGA T-125) which 
were synthesized, annealed, and cloned into BglII/HindIII sites of pSuper-neo 
(OligoEngine). The full cDNA of ATG9 was amplified by PCR using 
synthesic oligonucleotides (forward 5'-CCC AAG CTT GGG ATG GCG 
CAG TTT GAC ACT G-3' and reverse 5'-GGG GTA CCC CTA CCT TGT 
GCA CCT GAG GGG G-3') and the PCR products were subcloned into 




Cell Culture and DNA Transfection 
HEK293T (human embryonic kidney) cells and m5-7 (mouse fibroblast 
doxycycline-induced atg5) cells were cultured in DMEM (Hyclone) 
supplemented with 10 % (v/v) fetal bovine serum (FBS) (Hyclone). Hep3B 
(human hepatocelluarcarcinoma) cells were cultured in RPMI 1640 (Hyclone) 
supplemented with 10 % FBS (HyClone) at 37°C under an atmosphere of 5 % 
CO2. Transfection was carried out using Polyfect reagent (Qiagen) and 
mtHTT were transfected using Lipofectamine (Invitrogen) according to the 
manufacturer’s instructions.  
 
Cell-based Functional Screening Assay 
ULK1 and ATG9 cDNAs were amplified by PCR using synthetic 
oligonucleotides (pFLAG-ULK1-VN forward 5'-GAA GAT CTT CCG ATG 
GAG CCG GGC CGC GGC-3' and pFLAG-ULK1-VN reverse 5'- TGC TCT 
AGA GCA GGC ATA GAC ACC ACT CAG-3', pHA-ATG9-VC forward 5'- 
CGG GGT ACC CCG ATG GCG CAG TTT GAC AC-3' and pHA-ATG9-
VC reverse 5'- CGG GGT ACC CCG TAC CTT GTG CAC CTG AG-3'). The 
amplified PCR products were subcloned into BglII/XbaI site of pFlag-VN173 
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and KpnI site of pHA-VC155. HEK293T cells grown in a 96-well plate were 
co-transfected with pFLAG-ULK1-VN, pHA-ATG9-VC and an individual 
cDNA in a mammalian expression vector for 24 h. Serum starvation was 
treated 3 h before cells were observed under fluorescence microscope used as 
positive control (Olympus). 
 
Site-directed Mutagenesis 
G6PT (R28H, G149E, A373D) mutants were generated by a Quickchange 
Site-Directed Mutagenesis kit (Stratagene) using synthetic oligonucleotides 
containing mutations in the corresponding positions. All mutants were 
verified by DNA sequencing analysis. The nucleotide changes in the mutant 
constructs include: R28H (82-84, CGC  CAC); G149E (445-447, GGA  
GAA); A373D (1117-1119, GCC  GAC). 
 
Generation of Stable Cell Lines 
Hep3B cells were transfected with pcDNA3-HA, pG6PT-HA, pSuper-neo or 
pG6PT shRNA for 24 h and grown in the media containing 1 mg/ml G418 
sulfate (Invitrogen) for 2 weeks. Then, single clones of stable cells were 
isolated using the standard selection method and expression level of each 
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colony was analyzed by western blot analysis. 
 
Antibodies and Western Blot Analysis 
Cells were lyzed in RIPA buffer (50 mM Tris-Cl pH 7.5, 50 mM NaCl, 1% 
Triton X-100, 0.2% SDS, 1mM EDTA, 1 mM PMSF) and incubated in ice 
for 15 min. Cell lysates were clarified by centrifugation, resolved by SDS-
PAGE, and proteins on gels were transferred to polyvinylidenefluoride 
membrane (Millipore) using a semidry blotter (Bio-Rad). The membrane was 
blocked with 5 % BSA in TBS-T (10 mM Tris-Cl, pH 8.0, 150 mM NaCl, 
0.5% Tween-20) and incubated overnight at 4 °C with primary antibodies. 
Immunoblots were visualized by enhanced chemiluminescence method. The 
following antibodies were used for western blot analysis: LC3, ATG5, 
Beclin1 (Novus), ATG9A (Novus, Cell signaling), pS6K, S6K, pAMPK, 
AMPK, p4E-BP1, 4E-BP1, pULK1 (Cell signaling), FLAG (Sigma), p62 




Cells were lyzed in RIPA buffer (50 mM Tris-Cl pH 7.5, 50 mM NaCl, 1% 
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Triton X-100, 0.2% SDS, 1 mM EDTA, and 1 mM PMSF). After clarifying 
by centrifugation, cell lysates were incubated with anti-ULK1 antibody or 
FLAG (M2) bead (Sigma) for 12 h at 4°C. After adding protein A/G-Bead 
(Santa Cruz Biotechnology), the mixtures were incubated for additional 6 h 
at 4°C. The immunocomplexes were washed five times with PBS, solubilized 




Cells grown on coverslips were fixed with 4% paraformaldehyde (PFA) for 
15 min, rinsed three times with PBS, permeabilized with 0.1% Triton X-100 
for 1 min, and blocked with 1% BSA in PBS for 1 h. After incubation with 
antibody at 4 °C for 12 h, cells were rinsed with PBS three times, and then 
incubated with FITC-conjugated or TRITC-conjugated secondary antibodies 
(Jackson Laboratory Inc.) for 1 h. After rinsing three times with PBS, 
coverslips were incubated with Hoechst 33258 and placed with mounting 






Total RNA was purified using Trizol reagent (Ambion) according to the 
manufacturer’s instructions. The following primer sets were used for PCR: 
p62, forward 5′-ATG GCC ATG TCC TAC GTG AAG GAT G-3′ and reverse 
5′-AGA GGG CTA AGG GCA GCT GCC ACA C-3′; β-actin, forward 5′-
GAG CTG CCT GAC GGC CAG G-3′ and reverse 5′-CAT CTG GAA GGT 
GGA C-3′. 
 
Filter Trap Assay for mutant Huntingtin Aggregates 
HEK293T cells were co-transfected with pHTTex120-GFP and either 
pSuper-neo, G6PT shRNA #1, or G6PT shRNA #2 for 48 h. Cells showing 
mtHTT aggregates were observed under a fluorescence microscope. The 
pHTTex120-GFP, which is a fragment of Huntingtin (HTT) exon1 containing 
expanded polyglutamine (n=120) fused to GFP, was described (Lee et al., 
2012). For filter trap assay, HEK293T cells were transfected with 
pHTTex120-GFP for 24 h, harvested and washed with ice-cold PBS. Then 
the cells were briefly lyzed by sonication and added 1% SDS. Prepared 
samples are subjected to a filter trap using a 96-well dot blot apparatus (Bio-
Rad Laboratory). The membrane was washed with PBS containing 1% SDS, 






Differences between groups were analyzed using one-way analysis of 
variance (ANOVA) followed by Tukey’s post-hoc test, or Student’s t-test, as 
appropriate. Error bars represent S.D. or S.E.M., as indicated. P < 0.05 was 






Interaction between ULK1 and ATG9 in mammalian cells 
Based on the previous reports showing that Atg1 interacts with Atg9 
in Drosophila and yeast (Sekito et al., 2009; Tang et al., 2013), I first 
examined whether ULK1 interacts with ATG9 in mammalian cells. Data from 
the immunoprecipitation assay revealed that ATG9-FLAG interacted with 
HA-ULK1 in the transfected cells (Figure 1A and B). Moreover, I further 
found that endogenous ATG9 was immunoprecipitated together with 
endogenous ULK1 (Figure 1C), indicating that ULK1 interacts with ATG9 in 
mammalian cells as it revealed in other organism. These results led to 
establish a screening assay to identify autophagy modulators. Since the BiFC 
assay is a tool to observe protein-protein interactions in living cells, I adopted 
this method to identify novel proteins that regulate the initiation step of 
autophagy around ULK1. 
 
Establishment of the ULK1-VN/ATG9-VC BiFC assay to screen for 
autophagy activators 
To establish the BiFC assay, ULK1 was fused to the N-terminus of 
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the Venus vector (ULK-VN), while ATG9 was fused to the C-terminus of the 
vector (ATG9-VC) (Figure 2A). In the immunoprecipitation assay, I detected 
an interaction between ULK1-VN and ATG9-VC, which was apparently 
increased under serum starvation (Figure 2B). Following co-expression of 
ULK1-VN and ATG9-VC, I visualized the GFP-positive signal under a 
fluorescence microscope. Interestingly, various autophagic stimuli, such as 
rapamycin-treatment (Rapamycin), serum starvation (Serum (-)), and amino 
acid starvation (EBSS), significantly increased the fluorescence intensity 
about 60 % in cells expressing ULK1-VN/ATG9-VC, as compared with the 
control cells (Figure 2C). Together with result from immunoprecipitation 
assay, I assumed that interaction between ULK1 and ATG9 is regulated by 
autophagy stimulation. Therefore, adopting BiFC assay using ULK1-VN and 
ATG9-VC is suitable for screening. To confirm that fluorescence from BiFC 
assay is due to specific interaction between ULK1 and ATG9 but not a random 
collision, I further performed competition assay. The appropriate control of 
BiFC assay is expression of deletion mutants which interaction domains were 
removed. However, it was impossible to utilize the deletion mutant to confirm 
the BiFC assay on my system, therefore I performed competition assay 
instead. The result from competition assay showed that overexpression of the 
free form of either ATG9 or ULK1 (cold-ATG9 or -ULK1) together with 
ULK1-VN/ATG9-VC reduced the fluorescence intensity produced by BiFC 
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(Figure 2D). To eliminate the possibility that overexpression of both ULK1 
and ATG9 fully activates autophagy, I performed western blot analysis to 
detect autophagy. It revealed that serum starvation following ectopic 
expression of both ULK1-VN and ATG9-VC further increased LC3-II 
conversion but decreased the levels of p62 and ubiquitin-conjugates, well-
known autophagy substrates (Figure 3A and B). These results indicate that 
the ULK1-VN/ATG9-VC BiFC assay can be used as a tool for studying the 
interaction between ULK1 and ATG9, and to identify autophagy regulators 
that modulate this interaction. 
 
Identification of G6PT as an autophagy activator by cell-based functional 
screening  
By utilizing the ULK1-VN/ATG9-VC BiFC assay, I performed 
functional screening to isolate autophagy activator after transient expression 
of each 500 cDNAs which encode endoplasmic reticulum or lysosome-
resident proteins in mammalian cells. From the primary screening, I isolated 
14 putative positive clones which increased the BiFC fluorescence. From the 
secondary screening by observing LC3-II conversion, I isolated 5 positive 
clones. Because glucose-6-phosphate transporter (G6PT) was the most potent 
to increase both the fluorescence and LC3-II conversion among them, I 
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further characterized G6PT. As predicted, compared to control cells, ectopic 
expression of G6PT in HEK293T cells increased the intensity of ULK1-
VN/ATG9-VC BiFC about 20% (Figure 4A). Further, data from the 
immunoprecipitation assay confirmed that G6PT overexpression increased 
the interaction between ULK1-VN and ATG9-VC (Figure 4B and C). 
Consequently, ULK1-VN/Atg9-VC BiFC assay allowed me to successfully 
isolate autophagy activators from cDNA expression library, such as G6PT. 
 
Ectopic expression of G6PT increased autophagy flux 
To investigate whether G6PT enhance autophagic flux, I ectopically 
expressed G6PT in HEK293T cells and observed that G6PT increased LC3-
II conversion by western blot analysis. Because increment of LC3-II 
conversion does not fully understand for autophagy activation, further the 
cells were treated with Bafilomycin A1, a lysosomal inhibitor, to block 
lysosomal degradation and found that treatment of Bafilomycin A1 further 
increased LC3-II conversion (Figure 5A). Then I generated Hep3B cells 
expressing G6PT-HA stably (Figure 5B). Western blot analysis showed that 
LC3-II conversion was increased in Hep3B/G6PT-HA cells as compared with 
control cells, and this increment was further enhanced by the treatment with 
Bafilomycin A1 (Figure 5C). This indicates that the increment of LC3-II 
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conversion by G6PT overexpression is due to the activation of autophagy, but 
not inhibition of autophagy flux as I observed in HEK293T cells. Similar 
results were also observed using the GFP-LC3 puncta formation assay. 
Increased GFP-LC3 puncta by G6PT overexpression and further enhanced 
GFP-LC3 puncta formation under Bafilomycin A1 treatment (Figure 5D). 
Autophagic flux was further assessed with the mCherry-GFP-LC3 assay. 
Because mCherry is more stable in acidic pH than that acid-labile GFP, 
mCherry-only signal increases during autophagy activation. The results 
revealed that Hep3B cells expressing G6PT-HA showed great increment of 
red LC3 puncta (5-folds) as well as yellow LC3 puncta (2-folds) (Figure 5E 
and F), indicating that G6PT expression increased the formation of both 
autophagosomes and autolysosomes. Together, these data indicate that the 
increases of LC3 puncta formation and LC3-II level by G6PT overexpression 
are not due to blockage of the fusion of autophagosome with lysosome but 
are affected by the increase in autophagy flux. 
 
Beclin1 and ATG5-dependent regulation of G6PT-mediated autophagic 
flux 
The depletion of Beclin1, a key component of class III PI3K complex 
that regulates autophagy at the initiation step, blocked the increase in GFP-
22 
 
LC3 puncta induced by G6PT expression (Figure 6A). This result indicates 
that G6PT regulates autophagy at the initiation step, especially upstream of 
class III PI3K. Therefore it is appropriate for screening assay which propose 
to isolate autophagy regulator modulating at initiation step. As a recent study 
reported that alternative macroautophagy can occur independent of 
ATG5/ATG7 (Nishida et al., 2009), I tested whether this mechanism is 
involved in G6PT-induced autophagy using conditional Atg5-knockout 
mouse embryo fibroblasts (MEFs) (Hosokawa et al., 2006). Similar to the 
results obtained from experiments using Hep3B cells, ectopic expression of 
G6PT increased GFP-LC3 puncta formation in wild-type but not Atg5-/- 
MEFs (Figure 6B). This indicates that G6PT activates autophagy in an ATG5-
dependent manner.  
 
Depletion of G6PT caused accumulation of autophagy substrates by 
inhibiting autophagy activity 
Subsequently, I generated stable G6PT knockdown Hep3B cells 
(Hep3B/G6PT shRNA #1 and #2) to assess the effects of G6PT knockdown 
on autophagy. Using western blot analysis by anti-G6PT antibody, I detected 
two bands. Because there are actually five isoforms of G6PT with different 
sizes and among them, two bands were all reduced by G6PT knockdown, I 
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believe that those bands are G6PT isoforms. (Figure 7A). In comparison with 
control cells, Hep3B/G6PT shRNA cells exhibited a reduced basal level of 
LC3-II and an increased accumulation of autophagy substrates such as 
ubiquitin-conjugates and p62 (Figure 7B) (Ichimura et al., 2008). Similarly, 
monitoring the level of endogenous p62 with immunocytochemical analysis 
revealed the enhanced levels of p62 aggregates in G6PT-knockdown cells 
(Figure 7C). To identify whether the change of p62 level was not due to 
alteration of the mRNA level, I assessed RT-PCR to quantify mRNA levels in 
Hep3B/G6PT shRNA cells and observed no alteration in p62 mRNA level. 
Thus, accumulation of p62 in Hep3B/G6PT shRNA is due to inhibition of 
autophagy (Figure 7D). I also measured the aggregation of mutant Huntingtin 
(mtHTT), an autophagy substrate (Lee et al., 2012), in G6PT knockdown cells. 
Using the filter trap assay, I found that knockdown of G6PT expression 
increased the aggregation of GFP-fused mtHTT (Figure 8A and B). 
Consistent with the stimulatory effects of G6PT expression on autophagy, 
these results indicate that G6PT is crucial in autophagy activation.  
 
G6PT modulated autophagy independent of its transport activity 
Because G6PT functions as a transporter that dispatches cytosolic 
G6P into the ER lumen, I addressed whether the transport activity of G6PT is 
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associated with its autophagy activity. Based on a previous report (Chen et 
al., 2008a), I generated several transport activity-dead mutants of G6PT and 
tested their effects on autophagy. Like wild-type G6PT, all of the G6PT 
transport activity-dead mutants increased the levels of LC3-II conversion, 
GFP-LC3 positive puncta, and the fluorescence intensity in the ULK1-
VN/ATG9-VC BiFC assay (Figure 9A-C). Further, treatment with 
chlorogenic acid (CHA), an inhibitor of G6PT (Chen et al., 2008b), did not 
inhibit LC3-II conversion and GFP-LC3 puncta formation (Figure 9D and E). 
Consistently, I further tested whether G6PT transport activity is dispensable 
for autophagy activation using HT22 cells, non-gluconeogenetic cells. G6PT 
still increased LC3-II conversion and GFP-LC3 puncta formation in HT22 
cells. Moreover, ectopic expression of G6PT increased DFCP1-GFP puncta 
in HT22 cells (Figure 10A-C). These results indicate that G6PT affects 
autophagy activity in a transport activity-independent manner. 
 
C-terminus of G6PT might function to regulate autophagy 
The transport activity-independent function of G6PT in autophagy 
stimulation led to define the functional domain responsible for autophagy in 
G6PT. G6PT is composed of 10 transmembrane domains. Therefore, I deleted 
several transmembrane domains to generate C-terminal deletion mutants of 
25 
 
G6PT and tested their activities on autophagy (Figure 11A). In comparison 
with wild-type, G6PT deletion mutants were rapidly degraded in the 
transfected cells and thus detected only in the presence of MG132, a 
proteasome inhibitor. G6PT deletion mutants containing the N-terminal 4 or 
8 transmembrane domains but lacking the C-terminal transmembrane 
domains failed to increase GFP-LC3 puncta formation and LC3-II conversion 
(Figure 11B and C), indicating that the C-terminal region of G6PT may be 
required for its autophagy activity.  
 
G6PT activated autophagy by inhibiting mTORC1 during amino acid 
starvation 
In addition to its contribution to basal autophagy, I further assessed 
the role of G6PT in amino acid starvation-induced autophagy. Surprisingly, 
under amino acid starvation (with EBSS), the formation of both endogenous 
and ectopic LC3-positive puncta were abolished in Hep3B/G6PT shRNA 
cells but not in Hep3B control cells (Figure 12A and B). Additionally, LC3-
II level was decreased under amino acid starvation in Hep3B/G6PT shRNA 
cells compare to those of control cells (Fig. 12C). I further observed that 
subcellular distribution of ATG9-GFP were impaired in Hep3B/G6PT shRNA 
cells during amino acid starvation (Figure 13A and B). Because mTORC1 is 
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inactivated by amino acid starvation, I further illustrated that autophagy 
inhibitory effect in G6PT knockdown stable cells during amino acid 
starvation-induced autophagy is mediated by mTORC1. Western blot analysis 
illustrated that G6PT knockdown increased the level of phosphorylated S6 
kinase (Thr 389) and 4E-BP1 (Thr 37/46), direct substrates of mTORC1 (Ma 
and Blenis, 2009), on both nutrient supplemented and amino acid starved 
condition (Figure 14A). Also, this increment was eliminated by the treatment 
with Rapamycin, a mTORC1 inhibitor. Moreover, rapamycin treatment 
restored the level of LC3-II in Hep3B/G6PT shRNA cells (Figure 14B). 
Simultaneously, ULK1 phosphorylation S638 by mTORC1 was increased by 
G6PT knockdown but decreased by G6PT overexpression in Hep3B cells 
(Figure 14C and 15C). These results indicate that G6PT regulates autophagy 
through the inhibition of mTORC1 both basal and amino acid starvation-
induced autophagy. 
 
Down regulation of G6PT inhibits glucose starvation-induced autophagy 
by activating AMPK 
Because G6PT regulates autophagy separately with its transport 
activity, I assumed that G6PT regulates glucose starvation-induced autophagy 
besides amino acid starvation-induced autophagy. I observed that under 
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glucose starvation, G6PT knockdown reduced LC3-II conversion and GFP-
LC3 puncta formation. I further identified that the level of phosphorylated 
AMPK (T172) is reduced in Hep3B stably expressed G6PT shRNA during 
glucose starvation (Figure 15A and B). On the other hand, the 
phosphorylation of ULK S555 by AMPKα was increased by G6PT 
overexpression. Likewise wild-type G6PT, G6PT mutants similarly regulate 
mTORC1 and AMPKα (Figure 15C).  Together, these data indicate that 
G6PT regulates autophagy through the inhibition of mTORC1 and activation 




Figure I-1. Interaction between ULK1 and ATG9 in mammalian cells. (A 
and B) Interaction between ATG9-FLAG and HA-ULK1 in mammalian cells. 
HEK293T cells were co-transfected with pATG9-FLAG and pHA-ULK1 for 
24 h. Cell extracts were subjected to immunoprecipitation (IP) assay with 
anti-HA antibody (A) or anti-FLAG (M2) antibody (B). The 
immunoprecipitates and whole cell lysates (WCL) were analyzed by western 
blot analysis. (C) Endogenous interaction between ULK1 and ATG9. 
HEK293T cell extracts were subjected to immunoprecipitation assay using 






Figure I-2. Establishment of the ULK1-VN/ATG9-VC BiFC assay to 
screen autophagy activators. (A) Schematic diagram showing the BiFC 
assay using ULK1 and ATG9 as interacting proteins. A fluorescence protein, 
VENUS, is split into two parts. The parts containing the N- and C-terminal of 
VENUS, termed VN and VC, respectively, are fused with ULK1 and ATG9, 
respectively. Interaction between ULK1 and ATG9 brings VN and VC to a 
close proximity, generating a fluorescence signal that can be detected under a 
fluorescence microscope. (B) Increased interaction between FLAG-ULK1-
VN and HA-ATG9-VC under serum starvation. HEK293T cells were co-
transfected with pHA-ATG9-VC and pFLAG-ULK1-VN for 19 h and then 
incubated with either serum-supplemented or serum-free medium for an 
additional 3 h. Cell extracts were immunoprecipitated with anti-FLAG (M2) 
antibody. (C) Visualization of ULK1-VN/ATG9-VC association in living 
cells. HEK293T cells were co-transfected with pHA-ATG9-VC and pFLAG-
ULK1-VN for 19 h and then incubated with serum-supplemented, 
Rapamycin-containing (0.1 µg/ml) (Rapamycin), serum-free (Serum (−)), or 
amino acid-free medium (EBSS) for additional 3 h. Green fluorescence 
images of the complementation were acquired under a fluorescence 
microscope (GFP channel). Relative intensity of the BiFC fluorescence was 
measured using Multi Gauge V3.0 (Fuji film). Bars represent mean values ± 
S.E.M (n = 100). *** P < 0.001. (D) Competition assay showing the specific 
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interaction between ULK1-VN and ATG9-VC. HEK293T cells were co-
transfected with pFLAG-ULK1-VN, pHA-ATG9-VC, and either pATG9 
(cold ATG9) or pULK1 (cold ULK1) and cultivated in growth medium for 24 
h. GFP signals were observed under a fluorescence microscope and the 








Figure I-3. Expression of ULK1-VN and ATG9-VC increased autophagy.  
(A and B) Effects of serum starvation on autophagy in ULK1/ATG9 BiFC 
assay. HEK293T cells were co-transfected with pHA-ATG9-VC and pFLAG-
ULK1-VN for 19 h and then incubated with either complete medium or 
serum-free medium for additional 3 h. Cell extracts were examined with 
western blot analysis. Relative intensity of the western blot was measured 







Figure I-4. Identification of G6PT as an autophagy activator by cell-
based functional screening. (A) Enhanced BiFC signals of ULK1-
VN/ATG9-VC by G6PT overexpression. HEK293T cells were co-transfected 
with pHA-ATG9-VC, pFLAG-ULK1-VN, and either pcDNA3-HA (Ctrl) or 
pG6PT-HA for 24 h. Green fluorescence images of the complementation were 
acquired under a fluorescence microscope (GFP channel) (upper) and 
quantified using Multi Gauge V3.0 (Fuji film) (lower). * P < 0.05. (B) 
Enhanced binding between ATG9-VC and ULK1-VN by G6PT expression. 
After transfection with pHA-ATG9-VC, pFLAG-ULK1-VN, and either 
pcDNA3-HA or pG6PT-HA for 24 h, HEK293T cell extracts were analyzed 
with immunoprecipitation assay using anti-FLAG (M2) antibody. (C) 
Enhanced interaction between ATG9-VC and ULK1-VN by G6PT 
overexpression. HEK293T cells were co-transfected with pHA-ATG9-VC, 
pFLAG-ULK1-VN, and either pCMV-3xFLAG or pFLAG-G6PT for 24 h. 
Cell extracts were subjected to immunoprecipitation (IP) assay with anti-HA 
antibody. The immunoprecipitates and whole cell lysates (WCL) were 








Figure I-5. Ectopic expression of G6PT increased autophagy. (A) 
Increased LC3-II conversion by G6PT overexpression. HEK293T cells were 
transfected with pcDNA3-HA or pG6PT-HA for 24 h and then left untreated 
or incubated with 10 nM Bafilomycin A1 (Baf. A1) for 2 h before harvested. 
Cell extracts were analyzed with western blot analysis. (B) Generation of 
Hep3B/G6PT-HA stable cells. Hep3B cells were transfected with pcDNA3-
HA (Ctrl) or pG6PT-HA for 24 h, and then selected with G418 (1 mg/ml) for 
2 weeks. G6PT-HA expression was detected by western blot analysis. (C and 
D) Increase of autophagy activity by G6PT expression. Hep3B/Ctrl and 
Hep3B/G6PT-HA cells were either untreated or exposed to 10 nM 
Bafilomycin A1 (Baf. A1) for 2 h and cell extracts were subjected to western 
blot analysis (C). Hep3B/Ctrl and Hep3B/G6PT-HA cells were transfected 
with pEGFP-LC3 for 24 h in the presence or absence of 10 nM Baf. A1 Cells 
showing GFP-LC3 puncta (> 5) were counted under a fluorescence 
microscope (D). ** P < 0.01, *** P < 0.001. (E and F) Regulation of 
autophagic flux by G6PT expression. Hep3B/Ctrl and Hep3B/G6PT-HA cells 
grown on coverslips were transfected with pmCherry-GFP-LC3 for 24 h. 
After fixing the cells with 4% paraformaldehyde, green (upper) and red 
(middle) fluorescence images were acquired under a confocal microscope (E). 
The number of LC3 puncta showing GFP+/RFP+ or GFP-/RFP+ were counted 
and represented with bars (mean values ± S.E.M., n = 15). ** P < 0.01, *** 
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Figure I-6. Beclin1 and ATG5-dependent regulation of G6PT-mediated 
autophagic flux. (A) Hep3B/Ctrl and Hep3B/G6PT-HA cells were co-
transfected with pEGFP-LC3 and pSuper-neo (Ctrl) or Beclin1 shRNA for 72 
h. Cell extracts were subjected to western blot analysis (insert). (B) The m5-
7 cells were left untreated or treated with 10 ng/ml doxycycline for 3 days to 
induce Atg5 depletion. Cells were then co-transfected with pEGFP-LC3 and 








Figure I-7. Reduction of G6PT expression impaired autophagy. (A) 
Generation of stable G6PT-knockdown Hep3B cells. Hep3B cells were 
transfected with pSuper-neo (Ctrl) or G6PT shRNAs and selected with 1 
mg/ml G418 for 2 weeks. Stable Hep3B/G6PT shRNA cells (#1 and #2) 
showing reduced expression of G6PT were selected by western blot analysis. 
(B) Reduced autophagic flux in G6PT-knockdown cells. Hep3B/Ctrl and 
Hep3B/G6PT shRNA cells (#1 and #2) were left untreated or exposed to 10 
nM Bafilomycin A1 (Baf. A1) for 90 min and then analyzed by western blot 
analysis. (C) Accumulation of p62 in G6PT-knockdown cells. Hep3B/Ctrl 
and Hep3B/G6PT shRNA cells were grown on coverslips fixed with 4% 
paraformaldehyde, permeabilized with 0.1% Triton X-100, and stained with 
anti-p62 antibody (red channel) and Hoechst 33258 (blue channel) for nuclei. 
Images were acquired using a confocal microscope (upper) and the amounts 
of p62 were quantified (lower). Baf. A1-treated Hep3B/Ctrl cells were used 
as a positive control. * P < 0.05. (D) RT-PCR analysis showing p62 mRNA 
level in G6PT knockdown cells. Total RNA was purified from Hep3B/Ctrl 
and Hep3B/G6PT shRNA cells and analyzed by reverse transcriptase-
polymerase chain reaction (RT-PCR) using gene-specific synthetic primers. 








Figure I-8. Reduction of G6PT increased mutant Huntingtin aggregation. 
(A and B) Increased aggregation of mutant Huntingtin by G6PT depletion. 
Hep3B/Ctrl and Hep3B/G6PT shRNA cells were transfected with 
pHTTex120Q-GFP (mtHTT) for 24 h. Cell lysates were subjected to a filter 
trap assay and the blots were analyzed by western blotting using anti-GFP 
antibody. Ponceau S staining was used as loading control (A). HEK293T cells 
were transfected with pSuper-neo (Ctrl) or G6PT shRNAs for 24 h and further 
transfected with pHTTex120Q-GFP (mtHTT) for additional 24 h. Cells 









Figure I-9. G6PT stimulated autophagy activation independent of its 
transport activity. (A and B) Effects of G6PT transport activity-dead mutants 
on autophagy. HEK293T cells were transfected with various G6PT transport 
activity-dead mutants for 24 h. Cell extracts were analyzed by western 
blotting (A). Hep3B cells were co-transfected with pEGFP-LC3 and G6PT 
transport activity-dead mutants for 24 h. Cells showing GFP-LC3 puncta 
were counted under a fluorescence microscope (B). ** P < 0.01, *** P < 
0.001. (C) Effects of G6PT transport activity-dead mutants on the 
fluorescence intensity of ULK1-VN/ATG9-VC BiFC. HEK293T cells were 
co-transfected with pFLAG-ULK1-VN, pHA-ATG9-VC, and pG6PT-HA 
mutants for 24 h and observed under a fluorescence microscope. The 
fluorescence intensity of BiFC complex was quantified using Multi Gauge 
V3.0 (Fuji film). ** P < 0.01, *** P < 0.001. (D and E) Effects of chlorogenic 
acid on G6PT-mediated autophagy. HEK293T cells were treated with 1 mM 
chlorogenic acid (CHA) for 24 h and then treated with 10 nM Bafilomycin 
A1 (Baf. A1) for additional 2 h. Cell extracts were subjected to western blot 
analysis (D). Hep3B cells were transfected with pEGFP-LC3 for 16 h and 
exposed to 1 mM CHA for additional 24 h. Cells showing GFP-LC3 puncta 








Figure I-10. Ectopic expression of G6PT increases autophagic flux in 
HT22 cells. (A) HT22 cells were co-transfected with pEGFP-LC3 and either 
pcDNA3-HA (Ctrl) or pG6PT-HA for 24 h. Cells showing GFP-LC3 puncta 
were counted under a fluorescence microscope. ***p < 0.001. (B and C) 
HT22 cells were transfected with pcDNA-HA (Ctrl) or pG6PT-HA for 24 h 
and then examined with western blot analysis. (D) HT22 cells were co-
transfected with pDFCP1-GFP and either pcDNA-HA (Ctrl) or pG6PT-HA 
for 24 h. Cells showing DFCP1-GFP puncta (> 10) were counted under a 








Figure I-11. C-terminus of G6PT might function to regulate autophagy. 
(A) Schematic diagram of G6PT deletion mutants. (B and C) Domain 
mapping of G6PT for autophagy stimulation. Hep3B cells were co-
transfected with pEGFP-LC3 and G6PT deletion mutants for 24 h. Cells with 
GFP-LC3 puncta were counted under a fluorescence microscope. * P < 0.05, 
*** P < 0.001 (B). HEK293T cells were transfected with G6PT-HA deletion 
mutants for 24 h and then exposed to 5 µM MG132 for additional 6 h. Cell 








Figure I-12. Knockdown of G6PT inhibits autophagy activity. (A–C) 
Decrease of LC3 puncta formation and LC3-II conversion by G6PT 
knockdown under amino acid starvation. Hep3B/Ctrl and Hep3B/G6PT 
shRNA cells were incubated with EBSS for 2 h and immunostained with anti-
LC3 antibody (A). Hep3B/Ctrl cells and Hep3B/G6PT shRNA cells were 
transfected with pEGFP-LC3 for 24 h and then incubated with EBSS for 
additional 2 h. Cells showing GFP-LC3 puncta were counted under a 
fluorescence microscope. * P < 0.05, *** P < 0.001 (B). Hep3B/Ctrl and 
Hep3B/G6PT shRNA cells were exposed to EBSS for 2 h and cell extracts 








Figure I-13. Knockdown of G6PT expression altered ATG9-GFP 
distribution. Knockdown of G6PT expression affected sub-cellular 
distribution of ATG9. Hep3B/Ctrl and Hep3B/G6PT shRNA cells were 
transfected with pATG9-EGFP for 24 h and then incubated with EBSS for 2 
h. Cells showing ATG9-GFP puncta were counted under a fluorescence 








Figure I-14. G6PT activated autophagy by inhibiting mTORC1 during 
amino acid starvation. (A) Increase of mTORC1 activity by G6PT depletion. 
Hep3B/Ctrl and Hep3B/G6PT shRNA cells were exposed to EBSS for 2 h 
and subjected to western blot analysis. short, short exposure; long, long 
exposure. Relative intensity of the western blot was measured using ImageJ 
1.48v. (B) Hep3B/Ctrl and Hep3B/G6PT shRNA cells were either left 
untreated or treated Rapamycin (0.1 µg/ml) for 6 h. Cell extracts were 
analyzed by western blot analysis. (C) Enhanced phosphorylation of ULK1 
in G6PT depleted cells. Hep3B/Ctrl and Hep3B/G6PT shRNA cells were 
exposed to either full medium or EBSS for 2 h. Cells were then analyzed by 









Figure I-15. Down regulation of G6PT inhibits glucose starvation-
induced autophagy by activating AMPK. (A and B) Suppression of AMPK 
activity by G6PT knockdown under glucose depletion. Hep3B/Ctrl and 
Hep3B/G6PT shRNA cells were exposed to glucose-free medium for 2 h and 
subjected to western blot analysis. Relative intensity of the western blot was 
measured using ImageJ 1.48v (A). Hep3B/Ctrl and Hep3B/G6PT shRNA 
cells were transfected with pEGFP-LC3 for 24 h and incubated with glucose-
free medium for additional 2 h. Cells showing GFP-LC3 puncta were counted 
under a fluorescence microscope (B). ** P < 0.01, *** P < 0.001. (C) Effects 
of G6PT-HA deletion mutants on mTORC1 activity. HEK293T cells were 
transfected with G6PT transport activity-dead mutants for 24 h. Cell extracts 











In this study, I aimed to identify new regulators functioning at the 
initiation stage of autophagy. Based on a recent study showing a functional 
and physical interaction between Atg1, an ULK1 homolog, and Atg9 in yeast 
(Sekito et al., 2009), I developed a functional screening assay using the BiFC 
system to detect autophagy activation. Compared with the LC3 measurement 
assays, the BiFC assay using ULK1-VN and ATG9-VC provides an 
advantage in that fluorescence signal is generated only by autophagy 
activation but not autophagy inhibition, thus facilitating the successful 
identification of autophagy activators from a cDNA library. In particular, this 
assay is a viable method in monitoring the initiation step of autophagy 
upstream of ULK1 and ATG9. 
Similar to the case in yeast and Drosophila, I observed the protein-
protein interactions between ULK1 and ATG9 in mammalian cells with 
immunoprecipitation assays. Unlike in BiFC assays in which autophagy 
stimuli increased the fluorescence, I could not find convincing evidence 
showing that the interaction between endogenous ULK1 and ATG9 was 
regulated during autophagy in mammalian cells. In yeast, Atg1 has been 
shown to regulate Atg9 through their association (Sekito et al., 2009). The 
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absence of regulated interaction between endogenous ULK1 and ATG9 in 
mammalian cells may arise from a difference in the mode of interaction 
between ULK1 and ATG9 in yeast and mammalian cells. Alternatively, it may 
be easier to observe the regulated interaction between ULK1 and ATG9 in the 
BiFC assay than in the immunoprecipitation assay, since the interaction in the 
BiFC assay is irreversible (Kodama and Hu, 2012). Therefore, the mode of 
interaction between ULK1 and ATG9 in mammalian cells, whether direct or 
indirect, remains to be further elucidated.  
Although G6PT serves to transport G6P into the ER lumen during the 
cascade of gluconeogenesis or glycogenolysis to produce glucose, I could not 
observe any positive relationship between the transport activities of G6PT and 
autophagy. Accumulating evidence has implied that G6PT may have 
functions other than glucose production. First, G6PT is expressed all over the 
organ whereas G6Pase-α is only expressed in the liver and kidney. Second, 
GSD1b patients who carry G6PT mutations exhibit different symptoms from 
GSD1a patients who bear G6Pase malfunction. In addition to disruption of 
glucose homeostasis, GSD1b patients show neutropenia (Gitzelmann and 
Bosshard, 1993). Interestingly, although GSD1b patients have the same 
mutation in G6PT gene, the severity of neutropenia in the patients and their 
corresponding therapies are different (Melis et al., 2005). Recently, a G6pt−/− 
mouse model was developed to study the potential roles of G6PT beyond 
62 
 
glucose homeostasis in neutrophil cells. While G6pt-/- mice show same 
phenotype as G6Pase deficiency which is characterized by growth retardation, 
hypoglycemia, hepatomegaly, and nephromegaly, G6pt-/- mice also showed 
myeloid dysfunction, altered hematopoiesis in the bone marrow and spleen, 
abnormal chemokine production and impaired calcium flux in neutrophils 
(Chen et al., 2003). Although a number of studies are in progress, the 
relationship between neutropenia severity and transport activity of G6PT has 
not been clearly revealed. For these reasons, I suggest that the autophagy-
stimulatory activity of G6PT independent of its transport activity may be one 
of the additional functions of G6PT. I therefore encourage further 
investigation in identifying the functions of G6PT in autophagy and 
neutropenia on GSD1b patients. 
In this study, G6PT-mTORC1 signaling is essential in promoting 
autophagy in hepatic cell line. Malfunction of mTORC1 is frequently 
associated with metabolic diseases, including type 2 diabetes and cancer 
(Zoncu et al., 2011). Additionally, high levels of glucose in hepatic cells due 
to uncontrolled G6PT expression is widely observed in type 2 diabetic 
patients (Foster and Nordlie, 2002). Our observation that G6PT regulates 
mTORC1 and autophagy may provide a new way to interpret the role of G6PT 
in metabolic syndromes. In addition, G6PT is localized to the ER membrane 
whereas activated mTORC1 is found in the lysosome. Therefore, a question 
63 
 
remains as to how G6PT regulates mTORC1. One possible explanation is that 
G6PT regulates mTORC1 through calcium mobilization, because a recent 
study has revealed that knockdown of G6PT expression disrupts calcium 
mobilization in glioblastoma cells (Chen et al., 2003). Consistently, mTORC1 
is regulated by VPS34 in a calcium channel-dependent manner in the 
lysosome (Gulati et al., 2008). Especially, our observation that G6PT 
regulates AMPK during glucose starvation-induced autophagy suggests a 
pivotal role of G6PT in the regulation of mTORC1 through AMPK. AMPK 
is an energy sensor activated in response to increased cellular AMP, ADP or 
Ca2+ level and is phosphorylated by LKB1 and Ca2+/calmodulin-activated 
protein kinase β (CaMKKβ) (Mihaylova and Shaw, 2011). Because AMPK 
regulates autophagy through either direct phosphorylation of ULK1 or 
inhibition of mTORC1 (Hawley et al., 2005), disruption of calcium 
mobilization caused by G6PT dysfunction might affect both AMPK and 
mTORC1, resulting in inhibition of autophagy. 
In conclusion, I have established a functional screening assay using 
the BiFC system to study the interaction between ULK1 and ATG9. This 
assay enabled us to identify G6PT as a specific modulator of the initiation 
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Autophagy is a cellular degradation system for maintaining cellular 
homeostasis under various stress signals such as nutrient deprivation, hypoxic 
condition, or endoplasmic reticulum stress. To overcome the stress conditions, 
cells utilize autophagy-specific proteins to generate double-membrane vesicle 
called autophagosome to sequester cytosolic components and subcellular 
organelles to fuse with lysosome. However, molecular detail for the 
regulation of autophagy initiation under stress condition is not fully 
understood. Here, I show that ZAK kinase is an essential regulator of basal 
and induced autophagy. I first established ATG7-VN/VCn-ATG12 
bimolecular fluorescence complementation (BiFC) cell-based assay to isolate 
autophagy modulators which regulate interaction between ATG7, an E1-like 
activating enzyme, and ATG12. Utilizing the assay, I performed gain-of-
function screening of 900 cDNAs which encode mammalian kinases and 
phosphatases, and isolated ZAK as a potent autophagy activator. Ectopic 
expression of ZAK enhanced the fluorescence of ATG7-VN/VCn-ATG12 
BiFC assay and increased the interaction between them. Overexpression of 
ZAK reduced the levels of p62 and ubiquitin conjugates but increased LC3 
dot formation, leading to increase of autophagy flux, while ZAK K45M 
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kinase-dead mutant failed to do so. Conversely, knockdown of ZAK 
expression inhibited basal autophagy. Interestingly, down-regulation of ZAK 
blocked amino acid or serum starvation-induced autophagy to almost to 
control level. Furthermore, I found that ZAK interacted with ATG7 in cells. I 
hypothesize that ZAK is an essential regulator of autophagy which functions 






Autophagy is a cellular process that cytosolic components are 
destined to lysosome for its degradation (Ohsumi, 2014). Autophagy is 
classified by its degrading targets; mitophagy is mitochondrial degradation 
by autophagy (Kim et al., 2007; Youle and Narendra, 2011), pexophagy is for 
peroxisome-selective degradation (Dunn et al., 2005). Xenophagy is named 
for bacteria and virus clearance, while aggrephagy is degradation of protein 
aggregates such as polyQ-huntingtin (Randow and Munz, 2012; Yamamoto 
and Simonsen, 2011). Autophagy is also categorized according to its 
mechanism; macroautophagy, microautophagy, and chaperone-mediated 
autophagy (CMA). Unfolded substrates are directly translocated by CMA 
process across the lysosome membrane with the help of cytosolic,  
lysosomal chaperone HSC70 and the integral membrane receptor lysosomal-
associated membrane protein type 2A (LAMP-2A) (Cuervo and Dice, 1996). 
Microautophagy, relatively less studied, is a process in which portion of 
cytoplasm or organelles are directly sequestered by invagination of lysosomal 
membrane and subsequently engulfed by lysosome (Kunz et al., 2004; Li et 
al., 2012). Macroautophagy (hereafter autophagy), on the other hand, 
sequesters its cargoes within a unique double-membrane structure called an 
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autophagosome (Ohsumi, 2014). To generate autophagosome, several 
autophagy-related proteins (ATGs) are assembled to form phagophore. Then, 
concerted actions of ATGs function to expand and closure of phagophore to 
generate autophagosome (Feng et al., 2014). 
Among the ATGs, two ubiquitin-like systems are participated in 
autophagosomal membrane biogenesis and membrane expansion steps (Geng 
and Klionsky, 2008; Nakatogawa, 2013). Defects in the recruitment of 
ubiquitin-like proteins (UBLs) proteins to the expanding phagophore does not 
affect autophagosomal initiation step but fails to closure of autophagosome. 
These reports demonstrate that the two conjugation systems participate in the 
membrane expansion. Two ubiquitin-like proteins (UBLs), LC3 and ATG12, 
are first conjugated to E1 enzyme, ATG7, and transferred to ATG3 or ATG10, 
E2 enzymes. Then, ATG12 is eventually attached to ATG5 via isopeptide 
bond, while LC3 is conjugated to phosphatidylethanolamine (PE). For 
ATG12-ATG5 conjugation, E3 enzyme activity does not required since ATG5 
is directly recognized by E2 enzyme ATG10 (Yamaguchi et al., 2012b). 
Finally, ATG12-ATG5 conjugate binds to ATG16L1 with noncovalent bond 
that drives oligomerization of the ternary complexes. Unlike ATG12-ATG5 
conjugates, LC3-PE conjugate requires E3 enzyme activity that is function of 
ATG12-ATG5-ATG16L (Fujita et al., 2008). ATG12-ATG5-ATG16L1 
complex localizes on the expanding phagophore and is dissociated from the 
77 
 
membrane after the completion of autophagosome formation while LC3-PE 
is resided both inner and outer surface of the phagophore and remained on the 
inner surface after the membrane completion (Weidberg et al., 2010).  
ATG7, an E1-like enzyme for both ATG12 and LC3, has distinctive 
three functional domains. The N-terminal domain functions to recruit ATG3 
or ATG10 (Kaiser et al., 2012; Yamaguchi et al., 2012a). The C-terminal 
domain is required for its E1 activity and has roles in binding with substrates 
(Noda et al., 2011; Taherbhoy et al., 2011). The central domain of ATG7, 
adenylation domain, has several important main functions. First of all, the 
domain binds to UBL and Mg-ATP and catalyzes UBL activation. Second, it 
mediates homodimerization of ATG7 itself. Third, the central domain of 
ATG7 functions in the formation of thioester-linked ATG7-UBL intermediate. 
Last, this domain delivers the UBL’s C-terminus to its E2s (Hong et al., 2011; 
Komatsu et al., 2001). However, its regulation remains elusive. 
Since autophagy is tightly connected with human diseases and 
regulating autophagosome formation is a key mechanism, ATG proteins 
which belong to ubiquitin-like conjugation systems can be potential 
pharmacological target. ATG5 or ATG7 knockout mice were shown that 
autophagy is crucial for survival during neonatal starvation (Komatsu et al., 
2005; Kuma et al., 2004). According to studies in neurodegenerative disease, 
the function of autophagy is well characterized. In sporadic Parkinson’s 
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disease, altered expressions of ATG5 and ATG7 have been reported. 
Moreover, mutation in ATG7 has been informed to be associated with earlier 
onset of Huntington’s disease. (Chen et al., 2013; Metzger et al., 2010). 
Autophagy also contributes to immune responses. Not only autophagy 
directly engulfs and degrades pathogens, but also it mediates antigen 
presentation. In addition, down-regulation of ATG5 expression level 
increases susceptibility to bacterial infection (Nakagawa et al., 2004). 
Moreover, ATG12-ATG5-ATG16L1 complexes are needed for IFN-gamma-
mediated antiviral function. Mutation of ATG16L1 is tightly associated with 
Crohn’s disease caused by defective immunity (Hampe et al., 2007; Hwang 
et al., 2012; Saitoh et al., 2008).  
ZAK (sterile alpha motif and leucine zipper containing kinase AZK) 
belongs to the member of the MAPKK kinase (MAPKKK) family (Gallo and 
Johnson, 2002). There are two spliced forms of ZAK; ZAK-α is a longest 
form and ZAK-β is generated by alternative splicing with C-terminal 
truncation. ZAK contains several domains including N-terminal kinase 
catalytic domain, leucine zipper motif, and sterile-α motif (SAM). N-terminus 
of ZAK-β is identical to ZAK-α but has incomplete SAM domain (Gotoh et 
al., 2001). ZAK is mainly located on cytosol and binds to magnesium for 
homodimer formations. Studies on ZAK identified that ZAK suppresses cell 
proliferation (Yang et al., 2010). Moreover, it increases G2/M phase of cell 
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population, while expression of dominant-negative form of ZAK attenuates 
the G2 arrest by gamma-radiation (Gross et al., 2002). Also, overexpression 
of ZAK enhances LPA-stimulated invasion through direct binding with GTP-
bounded RhoA and RhoC (Korkina et al., 2013). ZAK regulates stress signal 
through extracellular signal-regulated kinase (ERK) or c-Jun N-terminal 
kinase (JNK). Lots of product associated with oncogenesis or tumorigenesis 
including MAPK/ERK have been reported to affect autophagy signaling. Ras-
Raf-MEK-ERK pathway is a chain of proteins that shares a signal from a 
small G protein receptor on the cell surface. Conversely, ZAK regulates stress 
signal through extracellular signal-regulated kinase (ERK) or c-Jun N-
terminal kinase (JNK) (Yang et al., 2010). However, its function in autophagy 
is not yet known. 
In this study, I isolated ZAK from functional screening as a potential 
regulator of autophagy. I propose that ZAK functions to regulate autophagy 




Materials and methods 
 
DNA Constructs 
The cDNA of ATG7 was amplified by PCR using synthetic oligonucleotides 
(forward 5′-CCG GGG TAC CCC GGG CGG CAG CTA CGG GGG-3′ and 
reverse 5′-GGG GTA CCC CGA TGG TCT CAT CAT CGC TC-3′). The 
amplified product was subcloned into KpnI site of pFLAG-VN173. To 
generate VCn-HA-ATG12, ATG12 cDNA was amplified by PCR using 
synthetic oligonucleotides (forward 5′-CCG CTC GAG CGG GCG GAG 
GAG CCG CAG TC-3′ and reverse 5′-CCG CTC GAG CGG TCA TCC CCA 
CGC CTG AGA CTT G-3′) and subcloned into XhoI site of pcDNA3-HA. 
Then, amplified product of VC155 (forward 5′-CCC AAG CTT GGG ATG 
TAC CCA TAC GAT GTT C-3′ and reverse 5′-CCC AAG CTT GGG CTT 
GTA CAG CTC GTC CAT G-3′) was subcloned into HindIII site of pHA-
ATG12. The cDNA of ZAK was amplified by PCR using synthetic 
oligonucleotides (forward 5′-CCG CTC GAA CGG TCG TCT CTC GGT 
GCC TCC-3′ and reverse 5′-GGG GTA CCC CTC ATT CAC TAT TAT CCA 
TGT C-3′) and subcloned into XhoI/KpnI site of pEGFP-C1. ZAK shRNAs 
were constructed using forward and reverse synthetic 19-base sequences (#1, 
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5′-921GCT TAA AGA ACG AGA AAG A-3′; #2, 5′-1010GAA TGT CTG AGG 
AGT CTT A-3′), which were cloned into BglII/HindIII sites of pSuper-neo 
(Oligoengine).  
 
Cell Culture and DNA Transfection 
HEK293T (human embryonic kidney) cells were cultured in DMEM 
supplemented with 10% fetal bovine serum (FBS) (Hyclone), penicillin, and 
streptomycin (Invitrogen). Hep3B (human hepatocellular carcinoma) cells 
were maintained in RPMI 1640 (Hyclone) supplemented with 10% FBS. 
Cells were cultured at 37°C under an atmosphere of 5% CO2. Transfection 
was carried out using Polyfect reagent (Qiagen) or PEI (Sigma) according to 
the manufacturer’s instructions.  
 
BiFC Assay for cDNA Library Screening 
HEK 293T cells grown in a 96-well plate were co-transfected with pFLAG-
ATG7-VN, pVCn-HA-ATG12 and an individual cDNA expression vector 
encoding kinase and phosphatase protein in a mammalian expression vector 
for 24 h. Treatment of Amino acid starvation (EBSS) for 2 h or 
overexpression of pULK1 was used as positive control. Green fluorescence 
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images of the complementation were acquired under a fluorescence 
microscope (GFP channel). 
 
Site-directed Mutagenesis 
ZAK K45M mutant was generated by a Quikchange Site-Directed 
Mutagenesis kit (Stratagene) using synthetic oligonucleotides containing 
mutations in the corresponding positions. Mutation was verified by DNA 
sequencing analysis. The nucleotide changes in the mutant construct include: 
ZAK Lys45Met (133AAG  133ATG). 
 
Antibodies and Western Blot Analysis 
Cells were lyzed in ice-cold RIPA buffer (50 mM Tris-Cl pH 8.0, 15 mM 
NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM PMSF, 
and 1 µg/ml each of aprotinin, leupeptin, and pepstatin A) and briefly 
sonicated. Cell lysates were clarified by centrifugation, resolved by SDS-
PAGE, and proteins were transferred to PVDF using semidry blotter (Bio-
Rad). The membrane was blocked with 3% BSA in TBS-T (10 mM Tris-Cl, 
pH 8.0, 150 mM NaCl, 0.05% Tween-20) and incubated overnight at 4 °C 
with primary antibodies. Immunoblots were visualized by enhanced 
83 
 
chemiluminescence method. The following antibodies were used for western 
blot analysis: LC3 (Novus), p62 (Abnova), actin, Tubulin, GFP, ZAK (Santa 
Cruz Biotechnology), and FLAG (Sigma).  
 
Immunoprecipitation Assay 
Cells were lyzed in RIPA buffer (50 mM Tris-Cl pH 7.5, 50 mM NaCl, 1% 
Triton X-100, 0.2% SDS, 1 mM EDTA, and 1 mM PMSF). After clarifying 
by centrifugation, cell lysates were incubated with anti-ZAK antibody or 
FLAG (M2) bead (Sigma) for 12 h at 4°C. After adding protein A/G-Bead 
(Santa Cruz Biotechnology), the mixtures were incubated for additional 6 h 
at 4°C. The immunocomplexes were washed five times with PBS, solubilized 
with sample buffer, and detected by western blotting as described above. 
 
Immunostaining 
Hep3B cells grown on coverslips in 24-well plates were co-transfected with 
pEGFP-ZAK and pFLAG-ATG7-VN for 24 h. Cells were then fixed with 4% 
paraformaldehyde for 15 min, permeabilized with 0.1% Triton X-100 for 1 
min, and blocked with 3% BSA for 1 h. After stained with anti-FLAG (Sigma) 
for 12 h at 4 °C and Hoechst 33258, cells were visualized under a LSM 
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confocal fluorescence microscope (Zeiss). For mCherry-GFP-LC3 
visualization, Hep3B cells were grown on coverslips in 24-well plates and co-
transfected with pmCherry-GFP-LC3 and either pcDNA3-HA or pZAK for 
24 h. Cells were then fixed with 4 % paraformaldehyde for 15 min, stained 




Total RNA was purified from HEK293T, HeLa, MCF-7, and Hep3B cells 
using Trizol reagent and subjected to amplification with SuperScript One-
Step RT–PCR system (Invitrogen). The following specific primers sets were 
used for PCR; p62, forward 5′-ATG GCC ATG TCC TAC GTG AAG GAT 
G-3′ and reverse 5′-AGA GGG CTA AGG GCA GCT GCC ACA C-3′; ZAK, 
forward 5′-ATG TCG TCT CTC GGT GCC TCC TTT G-3′ and reverse 5′-
GAG GTC TCT GTG AAT CAC CTT GAC-3′; β-actin, forward 5′-GAG 






Differences between groups were analyzed using one-way analysis of 
variance (ANOVA) followed by Tukey’s post-hoc test, or Student’s t-test, as 
appropriate. Error bars represent S.D. or S.E.M., as indicated. P < 0.05 was 





Establishment of the ATG7-VN/VCn-ATG12 BiFC assay to screen 
autophagy modulators 
ATG7 functions as an E1-like activating enzyme for ATG12, one of 
the substrates. ATG7 then transfers ATG12 to ATG5 through E2-like enzyme, 
ATG10 and the resulting ATG12-ATG5 conjugates sequentially interact with 
ATG16L1 that forms homodimer (Figure 1A). This ATG12-ATG5-ATG16L1 
multimer complex functions as E3-like ligase for LC3-PE 
(phosphatidylethanolamine), resulting in the expansion of autophagosome. 
To identify novel autophagy modulator which regulates Ubiquitin-like (UBL) 
conjugation system, I established ATG7-VN/VCn-ATG12 bifluorescence 
complementation (BiFC) assay which allows the detection of the interaction 
between ATG7 and ATG12 with fluorescence complementation in living cells. 
ATG7 was conjugated to the N-terminus of VENUS (VN173) to 
generate ATG7-VN. Because the C-terminus of ATG12 is modified for the 
conjugation, I conjugated VCn which is the C-terminus of VENUS (VC155) 
to the N-terminus of HA-ATG12 (Figure 1B). In this assay, it is important to 
note that monomeric form of ATG12 and ATG5 are present as well as ATG12-
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ATG5 conjugated form. As expected, when cells were overexpressed with 
ATG5-HA, I could detect both monomeric ATG5 (~38 kDa) and conjugating 
form with endogenous ATG12 (~60 kDa) (Figure 1C). This result indicates 
that not only ATG12-ATG5 conjugated form but also monomeric form of 
ATG5 or ATG12 are expressed in mammalian cells.  
 
ATG7-VN/VCn-ATG12 interaction is affected by autophagy signal 
Using immunoprecipitation assay, I first confirmed the endogenous 
interaction between ATG7 and ATG12 in HEK293T cells (Figure 2A). Then 
I checked the ATG7-VN/VCn-ATG12 BiFC assay. Ectopic expression of 
ATG7-VN and VCn-ATG12 in HEK293T cells visualized GFP signal under 
a fluorescence microscope (Figure 2B). To further validate whether 
autophagy signals affect the intensity of BiFC fluorescence, both ATG7-VN 
and VCn-ATG12-transfected cells were exposed to amino acid starvation 
(EBSS) or co-expressed with ULK1. As a result, I observed that EBSS 
treatment or ULK1 expression enhanced the BiFC intensity (Figure 2B). In 
contrast, co-expression of mTOR, an autophagy repressor which inhibits 
ULK1, reduced the GFP-positive signal (Figure 2B).  
Next, I addressed the direct interaction between ATG7-VN and VCn-
ATG12. The results from immunoprecipitation assay revealed that ATG7-VN 
88 
 
binds to VCn-ATG12 in the transfected cells (Figure 2C). In addition, I found 
that the interaction between ATG7-VN and VCn-ATG12 increased under 
amino acid starvation (EBSS) compared to that of control cells. On the other 
hand, this interaction between ATG7-VN and VCn-ATG12 did not increase 
under amino acid starvation condition by the pre-treatment with 3-
methyladenine (3-MA), a blocker of autophagosome formation (Figure 2C). 
As seen in the BiFC fluorescence, these results confirm that the interaction 
between ATG7 and ATG12 is regulated by autophagy signal.  
 
Isolation of autophagy modulators affecting ATG7-VN/VCn-ATG12 
BiFC 
By utilizing the ATG7-VN/VCn-ATG12 BiFC assay, I performed 
gain-of-function screening to identify novel autophagy regulators. I screened 
900 cDNAs in mammalian expression vector which encode kinase and 
phosphatase proteins in mammalian cells. After performing the primary 
screening of the cDNA library with the ATG7-VN/VCn-ATG12 BiFC assay 
in HEK293T cells, I isolated 22 putative positive clones which enhanced the 
BiFC intensity (Figure 3A). These putative positive clones were further 
assessed for their abilities to affect LC3-II conversion by secondary screening. 
To eliminate the possibility that the inhibition of autophagy also increases 
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LC3-II conversion, cells were treated Bafilomycin A1, a lysosomal inhibitor, 
to block lysosomal degradation. The results from western blotting showed 
that 9 clones among the 22 clones increased LC3-II conversion (Figure 3B).  
 
Isolation of ZAK by ATG7-VN/VCn-ATG12 BiFC assay 
Through the primary and secondary screenings, ZAK (sterile alpha 
motif and leucine zipper-containing kinase AZK) showed the most potent 
efficacy to induce autophagy among the putative positive clones. Therefore, 
I further investigated whether ZAK could regulate autophagy by affecting 
ATG7-ATG12 interaction. First, assessment with the ATG7-VN/VCn-ATG12 
BiFC fluorescence assay revealed that overexpressed ZAK enhanced the 
fluorescence of ATG7-VN/VCn-ATG12 BiFC (Figure 4A). Second, co-
immunoprecipitation assay followed by western blotting showed that ZAK 
significantly increased the interaction between ATG7-VN and VCn-ATG12 
in the transfected cells (Figure 4B). These results suggest that ZAK might 
regulate the interaction between ATG7 and ATG12 to modulate autophagy 
machinery. 
 
Depletion of ZAK increases the accumulation of p62 
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To determine the expressional levels of ZAK, RT-PCR analyses were 
performed in several cell lines. I found that ZAK was expressed in most of 
the cells with higher expression in Hep3B (Hepatocellular carcinoma) cells 
and MCF7 (Breast cancer) cells, and moderate level in HeLa (Cervical 
carcinoma) and HEK293T (Human embryonic kidney) cells (Figure 5A). 
Then I decided to knockdown ZAK expression with shRNA and assessed 
autophagy in the cells. Unfortunately, due to the limitation of antibody against 
ZAK, it was rare to detect endogenous levels of ZAK expression. Instead, I 
examined knockdown effects of ZAK shRNAs in HEK293T cells 
overexpressing exogenous ZAK.  
Western blot analysis revealed that ZAK shRNA#1 was marginal to 
reduce the level of overexpressed ZAK, while ZAK shRAN#2 was better and 
almost reduced ZAK expression (Figure 5B). Similarly, RT-PCR analysis 
revealed that ZAK shRAN#2 efficiently reduced the level of endogenous 
ZAK mRNA in HEK293T cells (Figure 5D). Then, I examined the 
degradation of autophagy substrate p62 in Hep3B cells. Immunocytochemical 
analysis revealed that compared to control cells, transfection with ZAK 
shRNA #2 increased the level of endogenous p62 in Hep3B cells (Figure 5C). 
Accordingly, knockdown of ZAK expression accumulated the levels of p62, 
consistent with the results of immunocytochemistry (Figure 5D). These 




ZAK is essential for starvation-induced autophagy and oxidative stress-
induced autophagy 
Since the functional role of ATG7 has been revealed in common 
autophagy machinery, ZAK was further investigated for its effect on 
starvation-induced autophagy. Under serum starvation, down regulation of 
ZAK inhibited both LC3-II conversion and GFP-LC3 puncta formation 
(Figure 6A and B). Further, under amino acid starvation (EBSS), knockdown 
of ZAK expression blocked the formation of GFP-LC3 puncta. Moreover, 
when Hep3B cells expressing GFP-LC3 were incubated with hydrogen 
peroxide (H2O2), the increased number of GFP-LC3 puncta was abolished in 
ZAK depleted cells. These results demonstrate that ZAK plays an essential 
role in both starvation-induced autophagy and oxidative stress-induced 
autophagy. 
 
Ectopic expression of ZAK increases autophagy flux 
Conversely, western blot analysis showed that overexpression of 
ZAK increased LC3-II conversion and this increment was further 
accomplished by Bafilomycin A1 treatment (Figure 7A), meaning that the 
increase of LC3-II is not due to the inhibition of autophagy flux. Accordingly, 
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overexpression of ZAK reduced p62 level in the cells. Consistently, the 
formation of GFP-LC3 puncta was increased by ZAK overexpression and this 
increase was blocked by the treatment with 3-methyladenine (3-MA), a class 
III PI3K inhibitor (Figure 7B). In addition, I measured autophagy flux using 
tandem mCherry-GFP-LC3 assay in which GFP is labile in acidic condition 
and the fluorescence therefore is lost in the lysosome, while mCherry is not. 
I discriminated the autophagosomes (GFP/RFP positive) from autolysosomes 
(RFP only signal). The results showed that overexpression of ZAK increased 
not only total number of LC3 puncta but also RFP only autolysosomes 
dramatically (Figure 7C). These observations indicate that overexpression of 
ZAK increases autophagy flux. 
 
Kinase activity of ZAK is required for the regulation of autophagy 
Because ZAK is a serine/threonine kinase, cells were further 
investigated whether the kinase activity of ZAK is essential for its effect. By 
immunoprecipitation assay, phosphorylated ZAK was detected, assuming 
kinase activity of ZAK might function to regulate autophagy (Figure 8A). 
According to the previous report (Wang et al., 2014), lysine 45 of ZAK is 
essential for it kinase activity. Thus I generated a kinase-dead mutant (ZAK 
K45M) with site-directed mutagenesis. Unlike wild-type ZAK, 
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overexpression of ZAK K45M did not reduce the levels of p62 and ubiquitin-
conjugates but rather increased those (Figure 8B). Similarly, overexpression 
of ZAK K45M did not enhance the formation of GFP-LC3 puncta (Figure 
8C), indicating that autophagy-stimulating activity of ZAK requires the 
kinase activity.   
The effect of ZAK K45M was further confirmed on starvation-
induced autophagy. Under amino acid starvation, I found that overexpression 
of ZAK potentiated amino acid starvation-induced autophagy (Figure 8C). 
Interestingly, overexpression of ZAK K45M suppressed amino acid 
starvation-induced GFP-LC3 puncta formation. Compared to GFP-LC3 
puncta formation (22%) in control cells, it was further reduced to 8% in ZAK 
K45M-transfected cells under amino acid-starvation condition (Figure 8C). 
These results indicate that ZAK K45M may act as a dominant negative mutant 
during amino acid- starvation condition. 
 
ZAK interacts with ATG7 
The observation that ZAK K45M may act as a dominant negative 
mutant led me to address whether ZAK binds to ATG7 or ATG12. Therefore, 
the interaction between ZAK and ATG7 was investigated in the cells. The 
results from immunoprecipitation assay revealed that ZAK bound to ATG7-
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FLAG in the transfected cells (Figure 9A and B). Immunocytochemistry 
assay also showed that GFP-ZAK co-localized with FLAG-ATG7 in the 
transfected Hep3B cells (Figure 9C). However, ZAK did not interact with 
ATG12 (data not shown). Unfortunately, there are no available antibodies 
against endogenous ZAK and ATG7 for immunocytochemical analysis. 
These results suggest that ZAK regulates autophagy through its interaction 




Figure II-1. Establishment of the ATG7-VN/VCn-ATG12 BiFC assay to 
screen autophagy modulators. (A) ATG12-ATG5 conjugation system in 
mammalian cells. (B) Schematic diagram showing ATG7-VN/VCn-ATG12 
BiFC assay. (C) Monomeric and conjugated forms of ATG5 in mammalian 
cells. HEK293T cells were transfected with ATG5-HA for 24 h. Cells were 










Figure II-2. Interaction between ATG7-VN and VCn-ATG12 is 
modulated by autophagy signal. (A) Endogenous interaction between 
ATG7 and ATG12. HEK293T cell extracts were subjected to 
immunoprecipitation (IP) assay using anti-ATG7 antibody. The 
immunoprecipitates and whole cell lysates (WCL) were analyzed by western 
blotting. (B) Visualization of ATG7-VN/VCn-ATG12 association in living 
cells. HEK293T cells were co-transfected with pVCn-HA-ATG12, pFLAG-
ATG7-VN and either pcDNA3 (Ctrl, EBSS), pULK1 or pmTOR for 19 h and 
then incubated with serum-supplemented full media (Ctrl, ULK1, mTOR) or 
amino acid-free media (EBSS) for additional 3 h. Green fluorescence images 
of the complementation were acquired under a fluorescence microscope (GFP 
channel). (C) Interaction between ATG7-VN and VCn-ATG12 is regulated by 
autophagy signal. HEK293T cells were co-transfected with pVCn-HA-
ATG12 and pFLAG-ATG7-VN for 19 h. Cells were then cultured with either 
full media or EBSS for additional 2 h or with full media containing 5 mM 3-
MA for 6 h. Cell extracts were subjected to immunoprecipitation (IP) assay 
with anti-HA antibody. The immunoprecipitates and whole cell lysates (WCL) 









Figure II-3. Isolation of the putative positive clones using ATG7-
VN/VCn-ATG12 BiFC assay. (A) Selection of putative positive clones 
enhancing ATG7-VN/VCn-ATG12 BiFC signal. HEK293T cells were co-
transfected with pVCn-HA-ATG12, pFLAG-ATG7-VN and each of 
mammalian expression cDNA Library for 24 h. Green fluorescence images 
of the complementation were acquired under a fluorescence microscope (GFP 
channel). Amino acid starvation (EBSS) and overexpression of ULK were 
used as positive controls. (B) Overexpression effects of the putative positive 
clones on LC3-II conversion. HEK293T cells were transfected with the each 
putative positive clones for 24 h and then treated with 10 nM Bafilomycin A1 
(Baf. A1) for additional 2 h. Cells were harvested and subjected to western 










Figure II-4. ZAK increases ATG7-VN/VCn-ATG12 BiFC signal and 
interaction between them. (A) Enhanced BiFC signals of ATG7-VN/VCn-
ATG12 by ZAK overexpression. HEK293T cells were co-transfected with 
pVCn-HA-ATG12, pFLAG-ATG7-VN, and either pcDNA3-HA (Ctrl) or 
pZAK for 24 h. Green fluorescence images of the complementation were 
acquired under a fluorescence microscope (GFP channel). (B) Enhanced 
binding between ATG7-VN and VCn-ATG12 by ZAK overexpression. After 
transfection with pVCn-HA-ATG12, pFLAG-ATG7-VN, and either 
pcDNA3-HA or pZAK for 24 h, HEK293T cell extracts were analyzed with 
immunoprecipitation (IP) assay using anti-FLAG (M2) antibody. The 











Figure II-5. Depletion of ZAK expression increases p62 accumulation. (A) 
RT-PCR analysis showing ZAK mRNA level in cell lines. Total RNA was 
purified from HEK293T, HeLa, MCF7, and Hep3B cells and analyzed by 
reverse transcriptase-polymerase chain reaction (RT-PCR) using gene-
specific synthetic primers. (B) Effect of ZAK shRNA on ZAK expression. 
HEK293T cells were co-transfected with pZAK and either pZAK shRNA#1 
or #2 for 48 h. Cells were harvested and subjected to western blot analysis 
using anti-ZAK antibody. (C) ZAK shRNA#2 accumulates p62 aggregates. 
Hep3B cells grown on coverslip were transfected with pSuper-neo (Control, 
Ctrl), pZAK shRNA #1, or pZAK shRNA #2 for 48 h. Cells were then fixed 
with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100, blocked 
with 3% BSA, and incubated with anti-p62 antibody for 12 h at 4℃. (D) 
Effect of ZAK shRNA on ZAK mRNA level and autophagy. HEK293T cells 
were transfected with pSuper-neo, pZAK shRNA #1, or pZAK shRNA #2 for 
48 h.  Cells were harvested for either western blot analysis (upper) or RT-
PCR (lower). Total RNA was purified and analyzed by RT-PCR using gene-










Figure II-6. Knockdown of ZAK inhibits starvation-induced autophagy 
and oxidative stress-induced autophagy. (A and B) Knockdown of ZAK 
expression inhibits serum starvation-induced autophagy. Hep3B cells were 
co-transfected with pEGFP-LC3 and either pSuper-neo, pZAK shRNA #1, or 
pZAK shRNA #2 for 48 h. Cells were further incubated with either full 
medium or serum-starved medium for 3 h. Cells showing GFP-LC3 puncta 
were counted under a fluorescence microscope (A). HEK293T cells were 
transfected with either pSuper-neo, pZAK shRNA #2, or pZAK shRNA #2 
for 24 h. Cells were then either exposed to full medium or serum-starved 
medium for 3 h and harvested for western blot analysis (B). Bars represent 
mean values ± S.D. (n > 3). (C) Knockdown of ZAK expression inhibits 
amino acid starvation-induced autophagy. Hep3B cells were co-transfected 
with pEGFP-LC3 and either pSuper-neo, pZAK shRNA #1, or pZAK shRNA 
#2 for 48 h and further incubated with either full medium or EBSS for 2 h. 
Cells showing GFP-LC3 puncta were counted under a fluorescence 
microscope. (D) Knockdown of ZAK expression inhibits autophagy in 
response to H2O2. Hep3B cells were co-transfected with pEGFP-LC3 and 
either pSuper-neo, pZAK shRNA #1, or pZAK shRNA #2 for 48 h, and the 
cells were left untreated (Veh) or treated with 0.5 mM H2O2 for additional 3 
h. Cells showing GFP-LC3 puncta were counted under a fluorescence 









Figure II-7. Ectopic expression of ZAK increases autophagy flux. (A) 
Overexpression of ZAK increases LC3-II conversion. HEK293T cells were 
transfected with either pcDNA3-HA or pZAK for 24 h in the absence or 
presence of 20 nM Bafilomycin A1. Cells were harvested for western blot 
analysis using the indicated antibodies. (B) Autophagy inhibitor 3-MA blocks 
ZAK-induced increase of GFP-LC3 dots. Hep3B cells were co-transfected 
with pEGFP-LC3 and either pcDNA3-HA or pZAK for 24 h and treated with 
5 mM 3-MA cells for 6 h before cells were harvested. Cells showing GFP-
LC3 puncta were counted under a fluorescence microscope. Bars represent 
mean values ± S.D. (n > 3). (C) Increase of autophagic flux by ZAK 
expression. Hep3B cells grown on coverslips were co-transfected with 
pmCherry-GFP-LC3 and either pcDNA3-HA or pZAK for 24 h. After fixing 
the cells with 4% paraformaldehyde, GFP green (upper) and mCherry red 
(middle) fluorescence images were acquired under a confocal microscope. 
The number of LC3 puncta showing GFP+/RFP+ or GFP-/RFP+ were counted 
and represented with bars (right) (mean values ± S.E.M., n = 21). ** P < 0.01, 









Figure II-8. Kinase activity of ZAK regulates autophagy. (A) Kinase 
activity of ZAK. HEK293T cells were transfected either pcDNA3-HA or 
pZAK for 24 h. Cell extracts were analyzed with immunoprecipitation (IP) 
assay using anti-phospho-Serine antibody. The immunoprecipitates and 
whole cell lysates (WCL) were analyzed by western blot analysis. (B and C) 
Kinase activity of ZAK is required for autophagy activation. HEK293T cells 
were transfected with either pcDNA3-HA, pZAK, or pZAK K45M for 24 h. 
Cells were then harvested for western blot analysis (B). Hep3B cells were co-
transfected with pEGFP-LC3 and either pcDNA3-HA, pZAK, or pZAK 
K45M for 24 h. Cells showing GFP-LC3 were counted under a fluorescence 
microscope (C). (D) Kinase activity of ZAK is required for amino acid 
starvation-induced autophagy. Hep3B cells were co-transfected with pEGFP-
LC3 and either pcDNA3-HA, pZAK, or pZAK K45M for 24 h. Cells were 
then incubated with either full medium or amino acid-free medium (EBSS) 
for 2 h. Cells showing GFP-LC3 were counted under a fluorescence 










Figure II-9. ZAK interacts and colocalizes with ATG7. (A and B) ZAK 
interacts with ATG7. HEK293T cells were transfected with pFLAG-ATG7-
VN and pZAK for 24 h. Cells were then subjected to immunoprecipitation 
(IP) assay with anti-FLAG (M2) (A) or anti-ZAK antibody (B). The 
immunoprecipitates and whole cell lysates (WCL) were analyzed by western 
blotting. (C) ATG7 co-localizes with ZAK. Hep3B cells grown on coverslip 
were co-transfected with pEGFP-ZAK and pFLAG-ATG7-VN for 24 h. Cells 
were then fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton 
X-100, blocked with 3% BSA, and immunostained with anti-FLAG antibody 










Figure II-10. Schematic diagram of ZAK-mediated autophagy as an 
ATG7 regulator. Under various autophagy stimulation signals, ZAK 
phosphorylates ATG7 to strengthen the interaction with ATG12, thereby 











 Studies on autophagy machinery revealed various ATG proteins and 
their concerted action to form auotphagosome. However, the precise 
mechanism for its upstream signaling and post-translational modifications of 
ATGs is not fully understood. Especially the activity and regulation of ATG7 
is not known. ATG7 is an E1-like enzyme and plays an important role in both 
ATG12-5 and LC3-PE conjugation. Unlike LC3-PE conjugates, it has been 
thought that ATG12-ATG5 conjugates are irreversible process. Moreover, it 
is still controversial whether unconjugated forms of ATG12 and ATG5 are 
detectable or not (Mizushima et al., 2001; Thompson et al., 2005). I observed 
that overexpressed ATG5 forms conjugation with endogenous ATG12 and is 
also present as a monomeric form. Because ATG7 acts like E1 enzyme to 
modulate two UBL conjugation systems that function to elongate the 
phagophore, it is important to understand the regulatory mechanism of ATG7 
modulation during autophagy.  
To isolate novel regulators autophagy, ATG7-VN/VCn-ATG12 BiFC 
assay was adopted. This assay is based on the interaction of ATG7-12 in the 
cells, as we also observed. Actually I also tried to establish ATG5-VN/VCn-
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ATG12 BiFC assay but could not observe any difference in the intensity of 
the fluorescence during autophagy (data not shown). In contrast, the intensity 
in the fluorescence of ATG7-VN/VCn-ATG12 BiFC assay reflects with the 
levels of autophagy activity. Thus, I employed this assay for the screening 
and identified ZAK as a most potent autophagy regulator. To my surprise, 
down-regulation of ZAK inhibited starvation-induced autophagy. For this 
activity, the kinase activity is essential. From this point of view, I conclude 
that the kinase activity of ZAK is indispensable for its regulation role in 
autophagy. Moreover, the observation that ZAK interacted with ATG7 further 
implies an autophagy regulatory role of ZAK by phosphorylating ATG7, 
which remains to be further addressed performed. It also remains to be 
investigated which domain of ZAK is required for ATG7-ZAK interaction 
and which Ser/Thr residues of ATG7 are modified by ZAK. Recently, 
constitutive (S230E, S234E) active forms of ZAK have reported to activate 
JNK and NF-κB signaling pathway mimicking the extracellular stimuli. It 
will be interesting to test whether kinase activity of ZAK is essential to ATG7 
for autophagy regulation using constitutively active form of ZAK. 
To adapt to the rapid alteration of environmental stress, cells utilize 
post-translational modification (PTM) to transit protein activity. Until now, a 
numbers of reports showed post-translational modifications of ATGs for 
autophagy regulation; phosphorylation, acetylation, and ubiquitination (Feng 
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et al., 2015). An E3 ubiquitin ligase, TRAF6 (TNF receptor-associated factor 
6) reported to ubiquitinate Beclin1 and ULK1 (Nazio et al., 2013; Shi and 
Kehrl, 2010). The Lys63 (K63)-linked ubiquitination of Beclin1 and ULK1 
leads to induction of autophagy. In addition, RNF5 (ring finger protein 5) 
ubiquitinates ATG4B to facilitate its degradation for autophagy inhibition. 
Acetylation is well-known to play a key role in the regulation of ATGs gene 
transcription. ULK1 is directly acetylated by KAT5/TIP60 and the 
modification results in autophagy initiation (Lin et al., 2012). Esa1, a yeast 
ortholog of KAT5 [K (lysine) acetyltransferase 5], is a diseases-associated 
gene, including HIV-1 and Kaposi's sarcoma. Esa1 acetylates Atg3 and 
accelerates Atg8-Atg3 interaction (Yi et al., 2012). Several major ATG 
proteins, including ATG5, ATG7, ATG12, and LC3 also experienced an 
acetylation via EP300/p300 (E1A binding protein p300) acetyltransferase, 
reducing their functions. Conversely, SIRT1 deacetylates ATG5, ATG7, and 
LC3 to enhance autophagosome formation. Acetylation also regulates 
FOXO3, a transcription factor, and the acetylated FOXO3 is interacted with 
an E1-like protein ATG7 to modulate autophagy by modulating protein–
protein interactions. (Attaix and Bechet, 2007; Zhao et al., 2007). 
Phosphorylation is the last form of PTM. To date, ULK1 is the only kinase 
whose kinase activity is modulated by phosphorylation among ATGs. 
mTORC1 and AMPK are the well-known upstream kinases for ULK1 
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phosphorylation to regulate autophagy initiation step (Jung et al., 2010; Kim 
et al., 2011). Phosphorylated Beclin1 by DAPK (death-associated protein 
kinase) disrupts the interaction between Beclin1 and Bcl-XL, therefore 
allowing beclin1 to associate with class III PI3K to activate autophagy 
(Zalckvar et al., 2009). More elucidation for the modification of autophagy 
machinery allows cells to adapt with distinct environments through autophagy.  
In addition to the function of ZAK in ATG7-ATG12 pathway, the role 
of ZAK as an E1-like enzyme for LC3-PE conjugate (Ichimura et al., 2000) 
remains to be further elucidated. In addition two isoforms of ZAK, ZAK-α 
(91 kDa) and ZAK-β (51 kDa), which are generated by alternative 
transcription (Gotoh et al., 2001) and have identical kinase domains, 
including the ATP binding site, need to be compared for their activity in the 
regulation of autophagy. Especially, ZAK-α, the longer form, contains SAM 
domain and thus the effect of ZAK-α on autophagy regulation and 
phosphorylation of ATG proteins should be defined. Further, characterization 
on upstream and downstream signaling of ZAK are needed for both ZAK-α 
and ZAK-β. In conclusion, this study first demonstrates a post-translational 
modification of ATG7 by ZAK which is now essential component in 
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세포자가섭식 작용 (영문: Autopahgy)은 세포질 내의 가
수 분해 효소를 함유한 기관중의 하나인 리소좀을 통해 자가포식 
소체 형성과정에 관여하는 이화과정이다. 세포는 여러 자가섭식 
관련 단백질 (ATGs) 을 이용하여 이중막 구조의 소포 구조를 가
지는 자가포식 소체 (autophagosome)를 생성하며, 자가포식 소
체는 리소좀과 결합함으로서 미토콘드리아 및 단백질 응집체 또는 
노화, 손상을 입은 세포질 내 구성요소를 제거한다. 세포자가섭식 
작용은 세포 사멸 및 병인 제거, 종양생성, 신경변성질환 및 노화 
를 포함한 세포내 항상성을 유지하는데 역할을 하기때문에 그 분
자적 기작을 이해 하는 것은 매우 중요하다. 현재까지 여러 자가
섭식 관련 유전자 (ATGs) 와 분자기작을 포함하는 그들의 기능
이 밝혀져 왔지만, 자가포식 소체의 개시 및 신장의 정확한 조절 
기작과 그 기능은 여전히 알려지지 않았다. 따라서 세포자가섭식 
과정의 새로운 조절자를 찾고 그 기작을 명확하게 하기 위해 저자
는 동물 세포에 기초한 이분자간의 상호 결합에 의해 형광을 발생 
시키는 (Bimolecular fluorescence complementation; 약어 
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BiFC) 스크리닝 방법을 도입하였다.   
저자는 세포자가섭식 과정을 매개하는 유전자들인 ULK1
과 ATG9 단백질간의 상호 결합을 확인하고 ULK1을 조절하는 
상위 단계의 조절자를 찾기위해 둘 간의 상호 결합을 이용하였다. 
두 유전자를 BiFC 분석 방법에 사용하였으며 이는 각각 BiFC의 
아미노 말단에 부착된 ULK1 과 카르복시 말단에 부착된  
ATG9 간의 결합에 의하여 세포내에서 형광을 발하게 된다.  이
를 동물 세포주를 이용하여 cDNA library 스크리닝 에 적용하였
으며 cDNA library 유전자를 과발현 시켜 그 기능을 회복 시켜
주는 스크리닝 방법을 응용하여 BiFC를 통해 세포자가섭식 과정
을 활성화 시켜주는 유전자로서 G6PT를 동정 하였다. G6PT는 
수송활성을 담당하는 단백질로서 ULK1과 ATG9 간의 상호 결
합을 강화 시켜 BiFC의 형광 활성을 증가 시켰으며 기존에 알려
진 G6PT의 수송활성능력과 별개로 자가섭식을 조절하는 기능을 
가지는 것을 확인하였다. 기작연구에 있어 mTORC1 단백질은 
자가섭식과정을 억제하는 역할을 한다. G6PT는 이러한 
mTORC1 단백질의 활성을 억제함으로서, 결과적으로 자가섭식 
과정을 활성화 시키며 따라서 mTORC1의 상위 단계에서 이를 
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조절함으로 자가섭식 과정을 조절한다.  
세포는 번역 후 수정(PTM) 에 의해 환경적인 스트레스에 
재빠르게 적응한다. 다양한 종류의 PTM 중 인산화에 의해 자가 
섭식의 신장단계를 조절 할 수 있는 유전자를 동정해내기 위하여 
두 자가섭식 관련 유전자를 사용하는 스크리닝 방법을 도입하였다. 
ATG7은 자가섭식 과정중 E1의 기능을 하며 ATG12는 그 기질
로서 자가섭식의 신장과정에서 중요한 기능을 하는 것으로 보고되
어 있다. 따라서 새로운 단백질을 동정하기 위하여 BiFC 를 도입
하여 아미노 말단에 부착된 ATG7 과 카르복시 말단에 부착된  
ATG12 을 제작하였다. 인산화와 탈 인산화를 관장하는 유전자
의 cDNA library를 동물세포에서 스크리닝 함으로서 잠재적인 
자가섭식 과정의 활성자인  ZAK을 동정하였다. ZAK 단백질을 
과발현 시켰을 경우 자가섭식의 활성이 증가 하였으며 반대로 세
포내에서 ZAK 의 발현을 줄여주었을 경우 영양분의 결핍에 의한 
자가섭식이 현저하게 감소하는 것을 관찰하였다. 따라서 ZAK이 
ATG7과의 결합과 그 인산화 활성을 통해 자가섭식 과정을 조절
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